Litcius/Paper detail

Bone Morphogenetic Proteins, Carriers, and Animal Models in the Development of Novel Bone Regenerative Therapies

Nikola Štoković, Natalia Ivanjko, Dražen Matičić, Frank P. Luyten, Slobodan Vukičević

2021Materials40 citationsDOIOpen Access PDF

Abstract

Bone morphogenetic proteins (BMPs) possess a unique ability to induce new bone formation. Numerous preclinical studies have been conducted to develop novel, BMP-based osteoinductive devices for the management of segmental bone defects and posterolateral spinal fusion (PLF). In these studies, BMPs were combined with a broad range of carriers (natural and synthetic polymers, inorganic materials, and their combinations) and tested in various models in mice, rats, rabbits, dogs, sheep, and non-human primates. In this review, we summarized bone regeneration strategies and animal models used for the initial, intermediate, and advanced evaluation of promising therapeutical solutions for new bone formation and repair. Moreover, in this review, we discuss basic aspects to be considered when planning animal experiments, including anatomical characteristics of the species used, appropriate BMP dosing, duration of the observation period, and sample size.

Topics & Concepts

Bone morphogenetic proteinSpinal fusionBone formationBone morphogenetic protein 2Bone healingRegeneration (biology)Animal modelBiomedical engineeringBiologyMedicineCell biologyAnatomySurgeryInternal medicineIn vitroBiochemistryGeneBone Tissue Engineering MaterialsPeriodontal Regeneration and TreatmentsSpine and Intervertebral Disc Pathology
Bone Morphogenetic Proteins, Carriers, and Animal Models in the Development of Novel Bone Regenerative Therapies | Litcius